FDA Inspection 1012540 — Lupin Limited

Lupin Limited — FEI 3007549629

The FDA completed an inspection of Lupin Limited on May 19, 2017 in Pithampur. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 19, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pithampur (India)